Tom,
There isn’t much in the world of lung cancer treatment I haven’t experienced. Everything short of actual surgery on my lungs.
Initial diagnosis is metastatic pulmonary adenocarcinoma, negative for genetic alterations involving EGFR, ALK, and ROS1. PD-L1 tumor proportion score is 0%.
Treatments so far include six cycles of carboplatin/weekly paclitaxel/bevacizumab, followed by 11 cycles of Alimta/bevacizumab, followed by maintenance bevacizumab through September 2016, and since February 2017 has been on nivolumab immunotherapy. I can offer support and answer questions about these treatments if there are any.
Kerry